PROCF — Procaps SA Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- $2.82m
- $277.55m
- $423.75m
Annual income statement for Procaps SA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 325 | 331 | 410 | 403 | 424 |
| Cost of Revenue | |||||
| Gross Profit | 182 | 191 | 236 | 235 | 238 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 287 | 268 | 339 | 372 | 393 |
| Operating Profit | 37.4 | 63.1 | 70.5 | 31.4 | 31.1 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -9.98 | 0.849 | -87.2 | 47.7 | 46 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -17 | -10.4 | -101 | 36.1 | 40.3 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -17 | -10.4 | -101 | 36.1 | 40.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -17 | -10.4 | -101 | 36.1 | 40.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.151 | -0.093 | -0.894 | 0.517 | 0.385 |
| Dividends per Share |